These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29363217)

  • 1. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.
    Schliessbach J; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Vuilleumier PH; Stamer U; Arendt-Nielsen L; Curatolo M
    PLoS One; 2018; 13(5):e0195776. PubMed ID: 29742109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain.
    Schliessbach J; Vuilleumier PH; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2017 Sep; 21(8):1336-1345. PubMed ID: 28418172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
    Weil AJ; Masters ET; Barsdorf AI; Bass A; Pixton G; Wilson JG; Wolfram G
    Health Qual Life Outcomes; 2017 Oct; 15(1):202. PubMed ID: 29041942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
    Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
    Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of static and dynamic quantitative sensory testing in patients with painful chronic pancreatitis.
    Olesen SS; van Goor H; Bouwense SA; Wilder-Smith OH; Drewes AM
    Reg Anesth Pain Med; 2012; 37(5):530-6. PubMed ID: 22854397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic effect of codeine as compared to imipramine in different human experimental pain models.
    Enggaard TP; Poulsen L; Arendt-Nielsen L; Hansen SH; Bjørnsdottir I; Gram LF; Sindrup SH
    Pain; 2001 May; 92(1-2):277-82. PubMed ID: 11323149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can quantitative sensory testing predict responses to analgesic treatment?
    Grosen K; Fischer IW; Olesen AE; Drewes AM
    Eur J Pain; 2013 Oct; 17(9):1267-80. PubMed ID: 23658120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative sensory tests (QST) are promising tests for clinical relevance of anti-nociceptive effects of new analgesic treatments.
    Jääskeläinen SK
    Scand J Pain; 2017 Oct; 17():144-145. PubMed ID: 28865379
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
    Webster LR; Butera PG; Moran LV; Wu N; Burns LH; Friedmann N
    J Pain; 2006 Dec; 7(12):937-46. PubMed ID: 17157780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
    Baron R; Likar R; Martin-Mola E; Blanco FJ; Kennes L; Müller M; Falke D; Steigerwald I
    Pain Pract; 2016 Jun; 16(5):580-99. PubMed ID: 26095455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial.
    Chang DJ; Desjardins PJ; Bird SR; Black P; Chen E; Petruschke RA; Geba GP
    Curr Med Res Opin; 2004 Jun; 20(6):939-49. PubMed ID: 15200753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.